Geneos Wealth Management’s Xtrackers USD High Yield Corporate Bond ETF HYLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$257K Buy
7,035
+24
+0.3% +$877 0.01% 916
2026
Q1
$254K Buy
7,011
+251
+4% +$9.22K 0.01% 886
2025
Q4
$249K Buy
6,760
+1,922
+40% +$70.8K 0.01% 856
2025
Q3
$180K Sell
4,838
-1,054
-18% -$38.8K ﹤0.01% 936
2025
Q2
$218K Sell
5,892
-48
-0.8% -$1.73K 0.01% 960
2025
Q1
$215K Buy
5,940
+689
+13% +$25.1K 0.01% 882
2024
Q4
$189K Sell
5,251
-1,361
-21% -$49.6K 0.01% 860
2024
Q3
$244K Sell
6,612
-1,983
-23% -$71.7K 0.01% 724
2024
Q2
$305K Sell
8,595
-4,776
-36% -$169K 0.01% 603
2024
Q1
$477K Sell
13,371
-2,249
-14% -$79.8K 0.02% 505
2023
Q4
$555K Sell
15,620
-2,146
-12% -$73.5K 0.03% 461
2023
Q3
$602K Sell
17,766
-4,573
-20% -$157K 0.03% 425
2023
Q2
$771K Sell
22,339
-5,894
-21% -$202K 0.04% 365
2023
Q1
$981K Buy
28,233
+5,123
+22% +$176K 0.06% 292
2022
Q4
$779K Buy
23,110
+3,513
+18% +$119K 0.05% 322
2022
Q3
$641K Buy
19,597
+5,419
+38% +$188K 0.04% 337
2022
Q2
$479K Buy
14,178
+3,578
+34% +$127K 0.02% 507
2022
Q1
$399K Sell
10,600
-3,812
-26% -$146K 0.02% 602
2021
Q4
$574K Buy
14,412
+5,100
+55% +$203K 0.02% 532
2021
Q3
$372K Buy
9,312
+8,757
+1,578% +$352K 0.01% 652
2021
Q2
$22K Sell
555
-1,471
-73% -$58.9K ﹤0.01% 1872
2021
Q1
$65K Buy
2,026
+170
+9% +$6.79K ﹤0.01% 1496
2020
Q4
$74K Buy
1,856
+88
+5% +$3.46K ﹤0.01% 1266
2020
Q3
$67K Sell
1,768
-3,575
-67% -$138K ﹤0.01% 1118
2020
Q2
$198K Buy
5,343
+4,482
+521% +$165K 0.01% 669
2020
Q1
$30K Sell
861
-935
-52% -$36.1K ﹤0.01% 1341
2019
Q4
$72K Buy
1,796
+50
+3% +$2K ﹤0.01% 1079
2019
Q3
$69K Buy
+1,746
New +$69.8K ﹤0.01% 1032
2019
Q2
Sell
-1,444
Closed -$57K 2507
2019
Q1
$57K Buy
+1,444
New +$56.5K ﹤0.01% 1082

Other funds holding HYLB

Geneos Wealth Management's HYLB Position: Q2 2026 in Review

Geneos Wealth Management increased its Xtrackers USD High Yield Corporate Bond ETF (HYLB) stake by 0.34% in Q2 2026, buying an estimated $877 and bringing the position to 7,035 shares worth $257K. The position accounts for 0.01% of the portfolio, ranked #916.

Geneos Wealth Management first reported a position in HYLB in Q1 2019 and has held it in 29 quarters since. The position peaked at $981K in Q1 2023. 238 funds tracked by Wall St. Rank hold HYLB as of Q2 2026.

  • Geneos Wealth Management held 7,035 shares of Xtrackers USD High Yield Corporate Bond ETF worth $257K as of Q2 2026.
  • Geneos Wealth Management bought 24 Xtrackers USD High Yield Corporate Bond ETF shares in Q2 2026, an estimated $877.
  • Xtrackers USD High Yield Corporate Bond ETF made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #916 holding.
  • Geneos Wealth Management first reported a position in Xtrackers USD High Yield Corporate Bond ETF in Q1 2019 and has held it in 29 quarters since.
  • Geneos Wealth Management's Xtrackers USD High Yield Corporate Bond ETF position peaked at $981K in Q1 2023.
  • 238 funds tracked by Wall St. Rank held Xtrackers USD High Yield Corporate Bond ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.